Augmedix, Inc. (AUGX)
NASDAQ: AUGX · Real-Time Price · USD
2.330
0.00 (0.00%)
Sep 18, 2024, 4:00 PM EDT - Market closed
Augmedix Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Augmedix stock have an average target of 5.25, with a low estimate of 5.00 and a high estimate of 5.50. The average target predicts an increase of 125.32% from the current stock price of 2.33.
Analyst Consensus: Buy
* Price targets were last updated on Apr 9, 2024.
Analyst Ratings
The average analyst rating for Augmedix stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 22, 2024 |
| Lake Street | Lake Street | Strong Buy Maintains $8 → $3.5 | Strong Buy | Maintains | $8 → $3.5 | +50.21% | May 14, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 14, 2024 |
| Evercore ISI Group | Evercore ISI Group | Hold → Buy Upgrades $4.5 → $5 | Hold → Buy | Upgrades | $4.5 → $5 | +114.59% | Apr 9, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $5.5 | Strong Buy | Initiates | $5.5 | +136.05% | Apr 3, 2024 |
Financial Forecast
Revenue This Year
54.16M
from 44.86M
Increased by 20.75%
Revenue Next Year
68.55M
from 54.16M
Increased by 26.57%
EPS This Year
-0.54
from -0.44
EPS Next Year
-0.48
from -0.54
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 56.1M | 75.5M | 65.1M |
| Avg | 54.2M | 68.6M | 63.2M |
| Low | 51.2M | 63.3M | 60.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 25.1% | 39.4% | -5.0% |
| Avg | 20.7% | 26.6% | -7.8% |
| Low | 14.0% | 16.9% | -11.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.47 | -0.46 | -0.37 |
| Avg | -0.54 | -0.48 | -0.36 |
| Low | -0.60 | -0.50 | -0.34 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.